A Pilot Single Arm Open Label Trial Evaluating M7824 (Anti-PD-L1/TGF-Beta TRAP) in a Window Setting in Patients With Stage II-III HER2/Neu Positive (HER2+) Breast Cancer (BC)
Phase of Trial: Phase 0
Latest Information Update: 15 Jan 2019
At a glance
- Drugs MSB 0011359C (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Pharmacodynamics
- 07 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 07 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 17 Aug 2018 New trial record